AUTH/2158/8/08: Pharmacist v Sanofi-Aventis — Acomplia reply-paid card fulfilment (No breach)

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2158/8/08
PartiesPharmacist practitioner v Sanofi-Aventis
MedicineAcomplia (rimonabant)
IssueAlleged failure to respond/fulfil a reply-paid card request for clinical studies and promotional items
Materials/items requestedCopies of four rimonabant clinical studies; laptop case; USB stick; laser pointer
Complainant preferenceIndicated he did not want to see a representative
Clause(s) assessedClause 9.1
DecisionNo breach of Clause 9.1
AppealYes — by the complainant; unsuccessful
Complaint received06 August 2008
Case completed13 November 2008
Applicable Code year2008

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A pharmacist practitioner complained that Sanofi-Aventis did not respond after he returned a reply-paid card for Acomplia (rimonabant).
  • The card stated NICE had recommended Acomplia for obesity and offered copies of four rimonabant clinical studies plus items the practice “would have found useful” (a laptop case, a USB stick and a laser pointer).
  • The complainant indicated he did not want to see a representative.
  • After around four weeks, the requested items had not been delivered and the complainant said no representative had called.
  • Sanofi-Aventis said it had no record of receiving the complainant’s card and assumed it was lost in the post; it described an agency/representative/warehouse process that typically took 8–12 weeks from card return to receipt of items.
  • The Authority asked Sanofi-Aventis to respond in relation to Clause 9.1.
  • The complainant appealed, disputing the “lost in post” explanation and arguing the company could have rectified the situation by delivering or posting the papers.
⚖️

Outcome

  • No breach of the Code was ruled by the Panel.
  • No breach of Clause 9.1 was upheld by the Appeal Board (appeal unsuccessful).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training